Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-18

Clinical Trial Update: Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin [Phase 4]

View source ↗

Summary

This Phase 4 trial compared three-times-daily unfractionated heparin to twice-daily enoxaparin for venous thromboembolism prophylaxis after trauma; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enoxaparin (enoxaparin sodium)
  • Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Scripps Health | Conditions: Venous Thromboembolic Disease, Deep Vein Thrombosis | Phase 4 | Status: COMPLETED | Results posted: 2016-07-18